As global healthcare standards regarding the stability, consistency, and biocompatibility of seals become increasingly stringent, the demand for customized medical seals is surging — driven by diverse application scenarios — and has emerged as a core trend in industry upgrading. Against this backdrop, Doit Rubber Products Co., Ltd. (international brand: DoitRubber) — a specialist in rubber sealing products — has leveraged its technical expertise in medical equipment and consumables to address common industry pain points associated with silicone stoppers for reagent kits. These issues include reagent incompatibility caused by the migration of volatile organic compounds (VOCs) from raw materials, failure to meet cytotoxicity standards, and needle-clogging errors during puncture resulting from the self-healing adhesion of stopper slits. Through targeted improvements in formulations and manufacturing processes, the company has successfully developed mature, localized solutions to resolve these challenges.
Medical silicone seals serve as critical foundational components for medical devices and in vitro diagnostic (IVD) consumables; their quality directly determines the safety of reagent storage and the operational stability of equipment. DoitRubber has designated medical silicone rubber sealing products as one of its core business segments. Its comprehensive product line encompasses a wide array of precision components — including silicone caps for IVD reagent kits, seals for cryovials, specialized silicone sheets for reagents, seals for ventilators, gaskets for nebulizers, and one-way valves for blood pressure monitors — and is widely utilized in key applications such as in vitro testing, respiratory care, and medical consumables.
Regarding quality control, DoitRubber has established a comprehensive compliance system and a Class 100,000 medical-grade clean production workshop, ensuring strict environmental control throughout the entire manufacturing process. Its medical sealing products have obtained multiple authoritative certifications — including ISO 13485 (medical device quality management system) and US FDA approval — and meet biocompatibility testing standards. Leveraging years of practical experience in the mid-to-high-end biomedical market, DoitRubber offers targeted product development based on specific equipment parameters and operating conditions; it flexibly handles OEM and ODM custom orders, precisely meeting the diversified and varied procurement needs of the medical market.
DoitRubber has achieved significant technological breakthroughs regarding silicone caps for IVD (in vitro diagnostic) reagent kits — precision components that undergo frequent piercing and come into direct contact with reagents. The company conducted a systematic, root-cause analysis to address two major challenges prevalent in the industry: first, issues involving the migration of chemical elements from the silicone, material-reagent incompatibility, and failures in cytotoxicity testing; and second, the problem of “self-healing” cuts in silicone products, which obstructs automated assembly probes during piercing and triggers system alarms.
The research revealed that the root causes of these persistent issues lie in several factors: the complex composition and low purity of traditional material formulations; laxity in manufacturing processes and parameter settings; and the incomplete removal of VOC (Volatile Organic Compound) components. Furthermore, the selected silicone materials lacked the inherent capability to prevent cut self-healing; this deficiency, compounded by unscientific manufacturing and storage conditions, accelerated the healing and adhesion of the pierced incisions.
To address this, DoitRubber has opted to utilize high-purity fumed silica or specialized medical-grade silicone — materials proven to pass biocompatibility testing — thereby enhancing material purity at the very source. Concurrently, the company has successfully developed a specialized silicone formulation featuring self-healing capabilities against incisions, while also optimizing conditions for product manufacturing, storage, and transportation to effectively prevent incision adhesion. This series of innovations has successfully resolved persistent issues — such as failures in cytotoxicity testing caused by residual VOCs, and needle-clogging errors during punctures resulting from the adhesion of self-healing silicone septa. Consequently, the safety, stability, and compatibility of DoitRubber’s medical seals have been significantly enhanced, fully meeting the mass production demands associated with the automated assembly of high-end medical equipment.
Currently, China’s domestic medical sealing industry is rapidly transitioning toward greater precision, customization, and regulatory compliance. With material R&D at its core and customized services as its strategic lever, DoitRubber continues to bridge the technological gaps within the domestic sector for precision medical seals. Moving forward, DoitRubber will further intensify its investment in the R&D of novel medical materials and expand its portfolio of medical sealing solutions across diverse application scenarios, thereby contributing to the high-quality development of the entire upstream and downstream supply chain for domestic medical devices.